Lung Cancer Susceptibility Gene Identified

Researchers have identified a lung cancer susceptibility gene (RGS17) that they believe may prove to be as important to lung cancer diagnosis and treatment as the BRCA1 and BRCA2 genes have proven to be in breast cancer. They believe the RGS17 gene might eventually be used to identify high-risk patients who may benefit from earlier, more aggressive lung cancer screening. The research was published in the April 15 issue of Clinical Cancer Research. [Press release]
Login Or Register To Read Full Story